Mortality and trends of pulmonary arterial hypertension, 1990–2021: a population-based study
PAH remains a major public health concern in some regions, particularly in high sociodemographic index region. Adequate diagnosis and targeted treatment of PAH are urgently needed to achieve a reduction in mortality.
Authors
- Yuchen He (ORCID: https://orcid.org/0000-0001-7335-3171)
- Linhong Jiang (ORCID: https://orcid.org/0000-0003-1061-1123)
- Hui Li (ORCID: https://orcid.org/0000-0002-5604-0592)
- Xiaodan Liu (ORCID: https://orcid.org/0000-0002-8379-0292)
- Peijun Li (ORCID: https://orcid.org/0000-0002-5303-009X)
- Xinliao Deng
- Yu Ai
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Institute of Applied Physics (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-09-03
- DOI
- https://doi.org/10.3389/fcvm.2025.1617610
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China